Jerrod Denham has worked in the cell therapy industry for 18 years with increasing roles of responsibility. At Geron Corporation, he was involved with research, process engineering, manufacturing sciences, pilot production, early stage manufacturing and dose administration in support of the world’s first IND for a human embryonic stem cell-derived product and its subsequent testing in a human clinical trial. In his latest role of Senior Manager, Process Engineering, he also led the technology transfer of both autologous and allogeneic product dose preparation procedures at 13 US clinical sites.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)